Alemtuzumab (Campath) is associated with high risk of CMV infection after liver transplant (LT).

作者:Stosor Valentina; Yu Edwin; Levistky Josh; Abecassis Michael; Ison Michael G
来源:Annual American Transplant Congress, 2007-05-05 to 2007-05-09.